Stefan N. Symeonides
Edinburgh, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 29, 2026
Germline pathogenic PTEN variant in a patient with a Kaposiform haemangioendothelioma.
Journal: Cancer genetics
Published: January 26, 2026
Sovereign AI supercomputers: a global landscape review of unprecedented biomedical research infrastructure.
Journal: Frontiers in artificial intelligence
Published: January 26, 2026
International Consensus-Driven Recommendations for Patient-Reported Outcome Research Objectives in Early Phase Dose-Finding Oncology Trials: OPTIMISE-ROR.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 23, 2026
Current landscape, successes, and key challenges in cancer vaccine clinical trials across the UK.
Journal: The Lancet. Oncology
Published: December 25, 2025
Innovative oncology trial designs: Time to act - A review with recommendations of the Cancer Drug Development Forum.
Journal: Journal of cancer policy
Published: December 02, 2025
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR).
Journal: The Lancet. Oncology
Published: October 26, 2025
Seamless monotherapy-combination phase I dose-escalation model-based design.
Journal: Clinical trials (London, England)
Published: July 12, 2025
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology.
Journal: British journal of cancer
Published: June 18, 2025
Leveraging knowledge for explainable AI in personalized cancer treatment: challenges and future directions.
Journal: Frontiers in digital health
Published: May 28, 2025
MANIFEST: Multiomic Platform for Cancer Immunotherapy.
Journal: Cancer discovery
Published: January 16, 2025
Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trial.
Journal: Nature cancer
Published: December 19, 2024
Last Updated: 09/26/2026